GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Dynatronics Corp (NAS:DYNT) » Definitions » Sloan Ratio %

Dynatronics (Dynatronics) Sloan Ratio % : -11.03% (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Dynatronics Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Dynatronics's Sloan Ratio for the quarter that ended in Dec. 2023 was -11.03%.

As of Dec. 2023, Dynatronics has a Sloan Ratio of -11.03%, indicating there is a warning stage of accrual build up.


Dynatronics Sloan Ratio % Historical Data

The historical data trend for Dynatronics's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dynatronics Sloan Ratio % Chart

Dynatronics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Sloan Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.58 -16.55 0.22 3.41 -17.15

Dynatronics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.30 -8.08 -17.15 -9.68 -11.03

Competitive Comparison of Dynatronics's Sloan Ratio %

For the Medical Devices subindustry, Dynatronics's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynatronics's Sloan Ratio % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dynatronics's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Dynatronics's Sloan Ratio % falls into.



Dynatronics Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Dynatronics's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(-4.973-0.371
--0.187)/30.063
=-17.15%

Dynatronics's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-4.968--1.443
--0.292)/29.299
=-11.03%

Dynatronics's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -1.245 (Mar. 2023 ) + -2.381 (Jun. 2023 ) + -0.331 (Sep. 2023 ) + -1.011 (Dec. 2023 ) = $-4.97 Mil.
Dynatronics's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was 0.113 (Mar. 2023 ) + -0.033 (Jun. 2023 ) + -1.665 (Sep. 2023 ) + 0.142 (Dec. 2023 ) = $-1.44 Mil.
Dynatronics's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -0.051 (Mar. 2023 ) + -0.01 (Jun. 2023 ) + -0.035 (Sep. 2023 ) + -0.196 (Dec. 2023 ) = $-0.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dynatronics  (NAS:DYNT) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Dynatronics has a Sloan Ratio of -11.03%, indicating there is a warning stage of accrual build up.


Dynatronics Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of Dynatronics's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Dynatronics (Dynatronics) Business Description

Traded in Other Exchanges
N/A
Address
1200 Trapp Road, Eagan, MN, USA, 55121
Dynatronics Corp is a United States-based company that is engaged in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, rehabilitation equipment, custom athletic training treatment tables and equipment, institutional cabinetry as well as other rehabilitation and therapy products and supplies. The company markets and sells its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions. It offers customers a one-stop-shop for their medical equipment and supply needs, including electrotherapy, therapeutic ultrasound, phototherapy, rehabilitation products, treatment tables, customized training room products, and exercise products.
Executives
Gabriel Ellwein officer: Chief Financial Officer 4782 HIGHCROFT COURT, EAGAN MN 55122
John Anthony Krier director, officer: Chief Executive Officer 319 WEST 50TH SOUTH, MINNEAPOLIS MN 55419
David B Holtz director 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Scott Klosterman director
R Scott Ward director 1064 S. CRESTVIEW CIRCLE, SLC VA 84108
Stuart Essig 10 percent owner 311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Erin S. Enright director 666 PLAINSBORO ROAD, PLAINSBORO NJ 08536
Brian Larkin director INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Brian D. Baker officer: Chief Operating Officer C/O SEASPINE HOLDINGS CORPORATION, 2302 LA MIRADA DRIVE, VISTA CA 92081
Provco Ventures 1 Lp 10 percent owner 795 E LANCASTER AVE SUITE 200, VILLANOVA PA 19085
Norman Iii Roegner officer: Chief Financial Officer 1200 TRAPP ROAD, EAGAN MN 55121
Skyler N Black officer: Corporate Controller 1448 E LEXI LN, COTTONWOOD HEIGHTS UT 84093
Keeler Jennifer Bennett Bennett officer: Secretary / General Counsel 8620 STILLWATER BLVD N, LAKE ELMO MN 55042
Daryl Connell officer: Chief Information Officer 932 MINJON DRIVE, APPLE VALLEY MN 55124
Cynthia L. Mchenry officer: VP, Operations 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT 84121